More on GSK (GSK +0.2%) Q4: CEO Andrew Witty says company is focused on organic growth and has...


More on GSK (GSK +0.2%) Q4: CEO Andrew Witty says company is focused on organic growth and has small appetite for acquisitions; GSK expects Phase III data on 14 assets in 2013 & 2014. Witty expects some job losses in Europe due to pressure on prices, and while he declines to provide too many details of impact on headcount of restructuring, he says the R&D and manufacturing overhaul will focus on new processes rather than staff cuts. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs